PT Siloam International Hospitals (SILO) Q1 2025 earnings summary

Executive summary

• Interim consolidated financials for the three months ended March 31, 2025, were prepared in accordance with Indonesian Financial Accounting Standards and reviewed by independent auditors, with no material misstatements identified.

• Management affirms responsibility for the accuracy and completeness of the financial statements and internal controls.

Financial highlights

• Revenue for Q1 2025 was Rp3,036,971 million, up slightly from Rp3,027,020 million in Q1 2024.

• Net profit for Q1 2025 was Rp255,803 million, a significant increase from Rp25,260 million in Q1 2024.

• Gross profit for Q1 2025 was Rp1,121,033 million, down from Rp1,155,431 million in Q1 2024.

• Operating profit rose to Rp373,507 million from Rp148,500 million year-over-year.

• Basic and diluted EPS for Q1 2025 were Rp18.93, compared to Rp1.05 in Q1 2024.

Outlook and guidance

• The company continues to focus on operational efficiency and expansion, with ongoing investments in hospital infrastructure and technology.

• Management expects to maintain a strong capital structure and liquidity position to support future growth.